AHL
MRVI icon

Abel Hall LLC’s Maravai LifeSciences MRVI Stock Holding History

Abel Hall LLC’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.5K Buy
12,908
+1,292
+11% +$4.38K 0.01% 765
2025
Q4 		$37.8K Buy
11,616
+136
+1% +$458 0.01% 675
2025
Q3 		$32.9K Buy
+11,480
New +$29.3K 0.01% 307

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Abel Hall LLC's MRVI Position: Q1 2026 in Review

Abel Hall LLC increased its Maravai LifeSciences (MRVI) stake by 11% in Q1 2026, buying an estimated $4.38K and bringing the position to 12,908 shares worth $36.5K. The position accounts for 0.01% of the portfolio, ranked #765.

Abel Hall LLC first reported a position in MRVI in Q3 2025 and has held it in 3 quarters since. The position peaked at $37.8K in Q4 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Abel Hall LLC held 12,908 shares of Maravai LifeSciences worth $36.5K as of Q1 2026.
  • Abel Hall LLC bought 1,292 Maravai LifeSciences shares in Q1 2026, an estimated $4.38K.
  • Maravai LifeSciences made up 0.01% of Abel Hall LLC's portfolio in Q1 2026, its #765 holding.
  • Abel Hall LLC first reported a position in Maravai LifeSciences in Q3 2025 and has held it in 3 quarters since.
  • Abel Hall LLC's Maravai LifeSciences position peaked at $37.8K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Abel Hall LLC's 13F filing for Q1 2026, filed 28 Apr 2026.